| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,173 |
11,974 |
$663K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,006 |
3,683 |
$310K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,533 |
2,389 |
$212K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,728 |
2,597 |
$118K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,248 |
2,152 |
$40K |
| 87428 |
|
1,519 |
1,423 |
$39K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
244 |
234 |
$34K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,815 |
4,573 |
$33K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
234 |
219 |
$12K |
| 3074F |
|
7,002 |
6,734 |
$12K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
228 |
215 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
142 |
135 |
$4K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,002 |
3,798 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
154 |
143 |
$3K |
| 96127 |
|
759 |
713 |
$3K |
| 81002 |
|
1,864 |
1,770 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
352 |
335 |
$3K |
| 3075F |
|
516 |
494 |
$891.00 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
150 |
141 |
$850.79 |
| 1160F |
|
9,419 |
9,017 |
$795.03 |
| 1125F |
|
5,187 |
4,957 |
$429.01 |
| 3078F |
|
5,641 |
5,416 |
$411.02 |
| 71046 |
Radiologic examination, chest; 2 views |
29 |
26 |
$334.78 |
| J3490 |
Unclassified drugs |
316 |
273 |
$300.72 |
| 1126F |
|
2,140 |
2,060 |
$192.00 |
| 3079F |
|
1,608 |
1,546 |
$147.02 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
15 |
14 |
$128.28 |
| 81025 |
|
25 |
25 |
$119.90 |
| 3077F |
|
158 |
151 |
$111.00 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
268 |
248 |
$97.62 |
| 82962 |
|
39 |
37 |
$47.74 |
| 1157F |
|
1,557 |
1,469 |
$42.00 |
| 3080F |
|
92 |
87 |
$15.00 |
| 1111F |
|
2,184 |
2,053 |
$0.00 |
| 3008F |
|
5,385 |
5,196 |
$0.00 |
| 1170F |
|
2,303 |
2,224 |
$0.00 |
| 4010F |
|
90 |
86 |
$0.00 |
| 3725F |
|
7,244 |
6,906 |
$0.00 |
| 1159F |
|
4,139 |
3,999 |
$0.00 |
| 3288F |
|
9,964 |
9,574 |
$0.00 |
| G0382 |
Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
475 |
410 |
$0.00 |
| G0383 |
Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
108 |
99 |
$0.00 |